Figures computed from official regulatory filings — .
Analysttarget 23 USD (+17%) · consensus 4.5/5 · 2 buy · 0 hold · 0 sell
Ownershipinsiders 6.4% · institutions 93.44% · short 3.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Anika Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
25 buys354 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Fishetti Gary P | Buy | $20.7K | conv 37First in 12mo |
| SEC |
| Fishetti Gary P | Buy | $20.3K | conv 28 | SEC |
| Fishetti Gary P | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CONLEY SHERYL L | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Capper Joseph Htrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HENNEMAN JOHN B IIItrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Richard Stephen | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Griffin Stephen D. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Griffin Stephen D. | Other | $54.3K | SEC |
| Griffin Stephen D. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HENNEMAN JOHN B IIItrack record | Buy | $73.3K | conv 42First in 12mo | SEC |
| Griffin Stephen D. | Buy | $149.9K | conv 55First in 12mo | SEC |
| McLeod Ian | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McLeod Ian | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McLeod Ian | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McLeod Ian | Other | $20.6K | SEC |
| McLeod Ian | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Colleran David | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Blanchard Cheryl R | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Colleran David | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Blanchard Cheryl R | Other | $171.9K | SEC |
| McLeod Ian | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Colleran David | Other | $26.9K | SEC |
| Colleran David | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Blanchard Cheryl R | Other | $209.1K | SEC |